|
Speaking of cheep, I personally am comfortable with the terms of the Myriad deal as we know them to be at this point in time. I'm positive that if there is a conference call today, Ira will be at the very least mentioning the deal and or terms. I reiterate my earlier sentiments( by the way it about 200 posts back ), when I say that even if the company shows an eps of .02 off of reoccuring and continuing operations, the stock is still undervalued. IMO, the .40 eps target for FAMH isn't unreasonable considering the mode of acquisitions that the company has been in. If you look at the bigger companies in the field (still doing my research), they have all become more profitable through acquisitions. Again, this is a BB stock, and there are certainly risks involved. That said, I have nowhere seen an official statement regarding reg s, and some of the other speculation that I have been culling through on the thread. The line of credit, IMO, is very positive. FAMH is in an exploding industry and seems to be growing. Good Luck, Jin. |
